Fosfomycin trometamol CAS:78964-85-9

Fosfomycin trometamol is frequently prescribed for uncomplicated urinary tract infections caused by susceptible bacteria, including Escherichia coli and Enterococcus faecalis. The single-dose oral formulation simplifies dosing regimens and offers efficacy comparable to traditional multi-day treatments. Patients typically take fosfomycin trometamol as a sachet or granules dissolved in water, allowing for easy administration and absorption. The mechanism of action involves inhibiting cell wall biosynthesis in bacteria, leading to bacterial death. This antibiotic's unique mode of action contributes to its effectiveness against multidrug-resistant pathogens. Healthcare providers may also consider fosfomycin trometamol for prophylactic use in certain surgical procedures to prevent postoperative infections. Dosage adjustments may be necessary based on renal function due to primarily renal excretion of the medication. Adherence to the prescribed dose and completion of the full course of treatment are essential to achieve optimal therapeutic outcomes and reduce the risk of recurrent infections or resistance development. Common side effects of fosfomycin trometamol may include gastrointestinal disturbances like diarrhea or nausea. Regular monitoring by healthcare professionals ensures treatment response and guides adjustments as needed. Fosfomycin trometamol represents a valuable option in the management of bacterial infections, emphasizing the importance of appropriate antibiotic use and patient education in promoting effective infection control strategies.